Showing results (1101-1110 of 6,155) with videos related to
Sort By:
Pageof 616
Nature Medicine|December 16, 2022
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Sarah Abou Alaiwi, Wenxin Xu, et al.Nature Medicine|December 5, 2022
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-PreservedStefan D Anker, Javed Butler, Muhammad Shariq Usman, et al.Nature Medicine|December 9, 2022
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trialAndreas Hagen Røssevold, Nikolai Kragøe Andresen, Christina Annette Bjerre, et al.Nature Medicine|June 8, 2022
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern CaliforniaJoseph A Lewnard, Vennis X Hong, Manish M Patel, et al.Nature Medicine|June 27, 2022
City-level impact of extreme temperatures and mortality in Latin AmericaJosiah L Kephart, Brisa N Sánchez, Jeffrey Moore, et al.Nature Medicine|June 17, 2022
Regenerative and restorative medicine for eye diseaseRussell N Van Gelder, Michael F Chiang, Michael A Dyer, et al.Nature Medicine|September 16, 2020
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control studySean T H Liu, Hung-Mo Lin, Ian Baine, et al.Nature Medicine|July 15, 2021
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccinationJoana Barros-Martins, Swantje I Hammerschmidt, Anne Cossmann, et al.Nature Medicine|July 10, 2021
A human three-dimensional neural-perivascular 'assembloid' promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathologyLu Wang, David Sievert, Alex E Clark, et al.Nature Medicine|January 2, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trialBenjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo, et al.Pageof 616